Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment
The Roche Digital Pathology Open Environment brings together a wide array of innovative AI-based pathology tools to help clinicians improve patient care and expand personalised healthcare.Roche ...
Larry Ellison's massive net worth, Huawei’s new smartphone, and the WeWork founder's crypto bust: Business news roundup
Boeing’s (BA) first foray into manned space flight has been an unmitigated cock up. Starliner launched to the International ...
Noise Annoys: Anthony Toner on Earlyriser, his short and sweet batch of guitar instrumentals
Noise Annoys catches up with the east Belfast based Co Derry singer-songwriter to chat about his new album of instrumentals, ...
Business Wire7d
Exelixis Presents Final Overall Survival Results from Phase 3 CONTACT-02 Pivotal Study Evaluating Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Metastatic ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced detailed final overall survival (OS) results from CONTACT-02, a phase 3 pivotal study evaluating cabozantinib (CABOMETYX ...
Roche Holding AG (RHHVF) Receives a Hold from UBS
In a report released today, Matthew Weston from UBS maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price ...
Roche Chairman Calls Industrial Subsidies a ‘Waste of Money’
Severin Schwan criticized the subsidies that the U.S. and European governments are using to boost their manufacturing ...
Berenberg Bank Sticks to Its Hold Rating for Roche Holding AG (RHHVF)
In a report released today, Luisa Hector from Berenberg Bank maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with ...
Roche shares knocked by concern over side effects in obesity pill trial
Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes ...
Roche says early-stage obesity pill results were based on just six patients
Roche said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its ...
Roche shares drop on side effects result in early-stage obesity pill trial
Shares in Roche fell on Thursday after an early-stage obesity pill candidate that carries high market hopes was linked to a ...
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.